Linked Life Data

15757413

Source:http://linkedlifedata.com/resource/pubmed/id/15757413

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2005-3-10
pubmed:abstractText
The Inflammation Research Association held its 12th international meeting at the Sagamore at Bolton Landing in New York State (3 - 7 October 2004). These meetings were originally intended for scientists from the pharmaceutical industry to get together and discuss the latest developments in inflammation drug discovery, and it remains an industry-dominated affair. The conference covered some highly topical issues such as cyclooxygenase-2 inhibitors (rofecoxib/Vioxx [Merck & Co., Inc.] was withdrawn from the market only a few days before the conference), along with areas of ongoing interest to the pharmaceutical and biotechnology industry, including p38 MAPK inhibitors, nuclear hormone receptor modulators and prostaglandin receptor antagonists. This review will cover the main themes that emerged during the meeting.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1744-7623
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
219-24
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
Inflammation Research Association: 12th international conference.
pubmed:affiliation
Array BioPharma, 3200 Walnut Street, Boulder, CO 80301, USA. David.chantry@arraybiopharma.com
pubmed:publicationType
Congresses